Coya Therapeutics
In David Einhorn's portfolio · Greenlight Capital
Ticker COYA
Still in the portfolio as of Q3 2026. Every quarter it shows up in a Greenlight Capital 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q3 2026 | No change | 2,335,540 | 0.3% |
| Q2 2026 | No change | 2,335,540 | 0.3% |
| Q1 2026 | Add 15% | 2,335,540 | 0.3% |
| Q4 2025 | Add 23% | 2,025,940 | 0.4% |
| Q3 2025 | No change | 1,646,440 | 0.4% |
| Q2 2025 | No change | 1,646,440 | 0.4% |
| Q1 2025 | No change | 1,646,440 | 0.5% |
| Q4 2024 | Add 29% | 1,646,440 | 0.5% |
| Q3 2024 | No change | 1,274,026 | 0.3% |
| Q2 2024 | No change | 1,274,026 | 0.4% |
| Q1 2024 | No change | 1,274,026 | 0.6% |
| Q4 2023 | Add 172% | 1,274,026 | 0.5% |
| Q3 2023 | Add 19% | 468,067 | 0.1% |
| Q2 2023 | No change | 392,647 | 0.1% |
| Q1 2023 | No change | 392,647 | 0.1% |
| Q4 2022 | Buy | 392,444 | 0.1% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.